295 related articles for article (PubMed ID: 24842896)
21. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.
Rocha MP; Maranhão RC; Seydell TM; Barcellos CR; Baracat EC; Hayashida SA; Bydlowski SP; Marcondes JA
Fertil Steril; 2010 Apr; 93(6):1948-56. PubMed ID: 19765700
[TBL] [Abstract][Full Text] [Related]
22. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
23. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
[TBL] [Abstract][Full Text] [Related]
25. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
Joham AE; Teede HJ; Hutchison SK; Stepto NK; Harrison CL; Strauss BJ; Paul E; Watt MJ
Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
[TBL] [Abstract][Full Text] [Related]
26. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
27. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
[TBL] [Abstract][Full Text] [Related]
28. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
[TBL] [Abstract][Full Text] [Related]
29. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
[TBL] [Abstract][Full Text] [Related]
30. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.
Mannerås-Holm L; Leonhardt H; Kullberg J; Jennische E; Odén A; Holm G; Hellström M; Lönn L; Olivecrona G; Stener-Victorin E; Lönn M
J Clin Endocrinol Metab; 2011 Feb; 96(2):E304-11. PubMed ID: 21084397
[TBL] [Abstract][Full Text] [Related]
31. Serum Amyloid A is a Novel Inflammatory Biomarker in Polycystic Ovary Syndrome.
Sun Y; Chen X; Ouyang B; Pan G; Sun L; Li S; Chen K
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115233
[TBL] [Abstract][Full Text] [Related]
32. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
33. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
34. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
[TBL] [Abstract][Full Text] [Related]
35. The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis.
Tan BK; Adya R; Shan X; Aghilla M; Lehnert H; Keay SD; Randeva HS
Atherosclerosis; 2011 Jun; 216(2):402-8. PubMed ID: 20869715
[TBL] [Abstract][Full Text] [Related]
36. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance.
Murdoch SJ; Carr MC; Hokanson JE; Brunzell JD; Albers JJ
J Lipid Res; 2000 Feb; 41(2):237-44. PubMed ID: 10681407
[TBL] [Abstract][Full Text] [Related]
37. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor.
Tzotzas T; Desrumaux C; Lagrost L
Obes Rev; 2009 Jul; 10(4):403-11. PubMed ID: 19413703
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.
Phelan N; O'Connor A; Kyaw-Tun T; Correia N; Boran G; Roche HM; Gibney J
J Clin Endocrinol Metab; 2010 Aug; 95(8):3933-9. PubMed ID: 20519354
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
40. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Altinkaya SÖ; Nergiz S; Küçük M; Yüksel H
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():168-72. PubMed ID: 24642195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
